Liver directed therapy: treatments for colorectal cancer metastasis
What is liver directed therapy?
Colorectal cancer can spread to other parts of your body through your blood or lymphatic system. The liver is the most common site of metastasis in patients with colorectal cancer, due to the blood supply that exists between the large intestine and the liver.
While liver metastasis can be very challenging to stop, there are options to consider for treatment.
Surgery can play an important role in treating liver metastasis for many patients. However, not everyone is a candidate for liver surgery.
There are a number of therapies that use chemotherapy, HAI therapy, ablation, radiation, cryotherapy, heat, and other approaches to reduce or remove liver metastases.
Because liver directed therapies are localized and target just the tumor, much of the surrounding tissue is spared. Many of these therapies are minimally invasive and have a short recovery time.
Approved liver directed therapies
Learn more about liver directed therapy
CRCtalks: Liver directed therapies for mCRCTop resources
Krazati approved for previously treated KRASG12C colorectal cancer
The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
Christy Williams: Biomarker testing leads to successful treatment
Statistics suggested that Christy’s odds of survival were grim, so she leaned into her faith and kept a positive outlook. She tried to control what she could. And, critically, she received biomarker testing.
EPIC Act to Advance New CRC Therapies Needs Support
The EPIC Act would encourage investment in clinical trials for additional uses of existing drugs.